DE60043390D1 - Stress-proteine extrazellulärer pathogene als impfstoffe gegen infektiöse erreger - Google Patents

Stress-proteine extrazellulärer pathogene als impfstoffe gegen infektiöse erreger

Info

Publication number
DE60043390D1
DE60043390D1 DE60043390T DE60043390T DE60043390D1 DE 60043390 D1 DE60043390 D1 DE 60043390D1 DE 60043390 T DE60043390 T DE 60043390T DE 60043390 T DE60043390 T DE 60043390T DE 60043390 D1 DE60043390 D1 DE 60043390D1
Authority
DE
Germany
Prior art keywords
vaccines against
against infectious
stress proteins
extracellular pathogens
proteins extracellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60043390T
Other languages
English (en)
Inventor
Camilo Anthony Colaco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunobiology Ltd
Original Assignee
Immunobiology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd
Application granted granted Critical
Publication of DE60043390D1 publication Critical patent/DE60043390D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE60043390T 1999-08-19 2000-08-18 Stress-proteine extrazellulärer pathogene als impfstoffe gegen infektiöse erreger Expired - Lifetime DE60043390D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9919734.5A GB9919734D0 (en) 1999-08-19 1999-08-19 Vaccines from infectious agents
PCT/GB2000/003228 WO2001013944A2 (en) 1999-08-19 2000-08-18 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents

Publications (1)

Publication Number Publication Date
DE60043390D1 true DE60043390D1 (de) 2010-01-07

Family

ID=10859501

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60043390T Expired - Lifetime DE60043390D1 (de) 1999-08-19 2000-08-18 Stress-proteine extrazellulärer pathogene als impfstoffe gegen infektiöse erreger

Country Status (14)

Country Link
EP (1) EP1204422B1 (de)
JP (1) JP2003507431A (de)
CN (1) CN100523192C (de)
AT (1) ATE449610T1 (de)
AU (1) AU6709900A (de)
CA (1) CA2382336C (de)
DE (1) DE60043390D1 (de)
DK (1) DK1204422T3 (de)
ES (1) ES2336417T3 (de)
GB (1) GB9919734D0 (de)
IL (2) IL148153A0 (de)
PT (1) PT1204422E (de)
WO (1) WO2001013944A2 (de)
ZA (1) ZA200201359B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004547D0 (en) * 2000-02-23 2000-04-19 Immunobiology Ltd Screening method for novel vaccine candidates and compositions obtained thereby
GB0021757D0 (en) * 2000-09-04 2000-10-18 Colaco Camilo Vaccine against microbial pathogens
WO2009021291A1 (en) * 2007-08-16 2009-02-19 The University Of Sydney Mycobacterium vaccine formulation
GB0910591D0 (en) 2009-06-19 2009-07-29 Immunobiology Ltd Method for the purification of protein complexes
GB0916557D0 (en) 2009-09-21 2009-10-28 Health Prot Agency Commensal neisserial stress protein complexes
GB201104897D0 (en) 2011-03-23 2011-05-04 Immunobiology Ltd Method for the production of protein complexes and vaccine compositions comprising the same
CN110240636A (zh) * 2019-06-04 2019-09-17 华中农业大学 牛分枝杆菌分子伴侣蛋白GroEL1及其编码基因与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002564A1 (en) * 1988-09-12 1990-03-22 Codon Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
JPH11507214A (ja) * 1995-06-07 1999-06-29 バイオケム ヴァシーンズ インク． Ｈｓｐ７０ファミリーに属する連鎖球菌の熱ショック蛋白質メンバー

Also Published As

Publication number Publication date
GB9919734D0 (en) 1999-10-20
CN1556856A (zh) 2004-12-22
AU6709900A (en) 2001-03-19
ATE449610T1 (de) 2009-12-15
EP1204422A2 (de) 2002-05-15
CN100523192C (zh) 2009-08-05
IL148153A (en) 2011-04-28
CA2382336A1 (en) 2001-03-01
DK1204422T3 (da) 2010-03-15
WO2001013944A3 (en) 2001-09-20
IL148153A0 (en) 2002-09-12
JP2003507431A (ja) 2003-02-25
ZA200201359B (en) 2003-07-30
ES2336417T3 (es) 2010-04-13
CA2382336C (en) 2012-07-10
PT1204422E (pt) 2010-02-05
WO2001013944A2 (en) 2001-03-01
EP1204422B1 (de) 2009-11-25

Similar Documents

Publication Publication Date Title
NO20111324A1 (no) Rekombinant MVA-virus
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
DE602004023094D1 (de) Lawsonia intracellularis europäischen ursprungs unür
ATE556596T1 (de) Regulierte attenuierung von lebendimpfstoffen zur verbesserung der kreuzimmunitätsschutzfunktion
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
ATE272410T1 (de) Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
NO20054608L (no) Influensavirusvaksine
DE60226911D1 (de) Entwicklung einer Vakzine zur Prävention von Infektionen mit Filovirus bei Primaten
ATE452900T1 (de) Impfstoff gegen das west-nile-virus
FR2827605B1 (fr) Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
DE60043390D1 (de) Stress-proteine extrazellulärer pathogene als impfstoffe gegen infektiöse erreger
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
DE602004028029D1 (en) Rwendung
WO2001063278A3 (en) Antigenic fragments associated with stress-induced proteins and their use as vaccines
DK1395283T3 (da) Heterolog beskyttelse induceret ved immunisering med Invaplex-vaccine
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
SE9903534D0 (sv) Vaccin
ATE450270T1 (de) Impstoff gegen mikrobielle pathogenen
ATE413887T1 (de) Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene
DE602005021873D1 (de) Neues impfstoffadjuvans und dessen herstellung und verwendung
ATE439858T1 (de) Vakzine zum schutz von tieren gegen leishmania
EA200400534A1 (ru) Стимуляция тимозином генетической иммунизации
ATE359811T1 (de) Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe

Legal Events

Date Code Title Description
8364 No opposition during term of opposition